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
G 11245 $@A 671245 $@A 11245 1124 671248 671245 % 5 Y%-+%.41*(*, 11245 $@A 671245 $@A 11245 1124 671248 671245 G P \ 3 CG 5P \ 3 8G 5P \ 3 G 5P C \ 3 BG P 5 \ G P \ 3 11245 11245 $@A 1124 671245 $@A 671245 U BG B8 671248 1124 U BG B8 11245 1124 671245 $@A 671248 U BG BC 11245 $@A 1124 U BG BC 3 0 1124 U BG B8 L 11245 $@A U BG BC 11245 $@A 11245 1124 U BG B80 U BG BC 11245 1124 671248 671245 11245 G A 8BBB W ]5BB 3B W B W B 8B C D 5BB8 8 5 D CG C 7 8B C C 0 L 2 671245 11245 671245 8 CM4NAA NA NN 6N A NA NA NNA NN NA4MO 53 CM4N6A NA6 AAA 6 6A6 A6 66 6 ANN 4MO 3 CM46NN N6 6 NA6 N6 NAN AAA 6 6N 664M 11245 8 CM4N66 NA N6 6 66 NNN NA N A6A NAA4MO 53 CM4NNA AN NNA A6N NAA A6 6N ANN N6 N64MO 3 CM4A AA 66 AN 6 66 ANA 66 6NN 664M 671248 671245 11245 1124 $ 8BP $$0 $%& ( $*&%++,-,&*(.%/*/0 112/3 11245 1124 3 CQ D BQ : 671245 11245 AL +& %R*./(&(S* 61 R2 671248 2TR AL 11245 1124 671245 671248 &(//9* (.:(;(&, /, % 671245 $@A 11245 $@A $%& ( $*&%++,-,&*(.%/*/ 3 = 8 11245 1124 671248 671245 $@A 11245 1124 671248 671245 11245 1124 671248 671245 B 8 5 U CP B CP D 5CP 8 5P D CBP 5 V CBP B W 8 X & R2RR8BG B % 5 Y%-+%.41*(* +,Z4 %.[
范松青 等 $ 基质金属蛋白酶及其抑制剂在乳腺癌中的表达及其临床意义 验 和 %& 多因素回归预后分析 结 果 乳 腺 癌 $$%& (* +,$%& (* 和 白的阳性表达率分别为 ;$,3 4 5 6 (( 7 ($,3 4 58 6 (( 7 5$ 3, 6 (( ($ 3 4 5( 6 (( 7 阳性表 达 信 号 均 位 于 乳 腺 癌 细 胞 浆 见 图 ; 乳 腺 癌 12*+, -./0 *+, -./0 和 *+, *+ $$%& $$%&- +,$%& +,$%& 蛋白的表达及相 12*+, 12*+; 蛋白表达的相互关系见表 ; 12*+, 互关系 -./0 与 12*+, 蛋 白 及 *+, 蛋 白 与 *+, -./0 *+ 蛋白在乳腺癌中的表达存在显著性 正相关 = $ ; 乳腺癌中 12*+; 与 *+ 蛋 (( 例乳腺癌中 *+, -./0 和 12*+, -./0 的阳性表达率为 (($ 3 4 55 6 (( 7 和 (8$,3 4 59 6 (( 7 : 乳腺癌中 *+, *+ 12*+; 12*+, 蛋 白表达呈显著性负相关 = $ ; 图; 乳腺癌 *+,-./0 12*+,-./0 原位杂交和 *+, *+ 12*+; 12*+, 免疫组化染色 >@$ ; 2A BCD GC&A &L *+, -./0M 12*+, -./0 A --DA&BC&NO-NP BCAA@ &L *+,M *+M 12*+;M A 12*+, 0Q *&BCRO O SOBB&A &L *+,-./0 A CO SPB- &L ARBRO DNCP GOBC NNA&- NOPPB 4 2TU V 5 7 W *&BCRO O SOBB&A &L 12*+,-./0 A CO SPB- &L ARBRO DNCP GOBC NNA&- NOPPB 4 2TU V 5 7 %Q *&BCRO O SOBB&A &L *+, S&COA A CO SPB- &L ARBRO DNCP GOBC NNA&- NOPPB 4 T* V 5 7 XQ *&BCRO O SOBB&A &L *+ S&COA A CO SPB- &L ARBRO DNCP GOBC NNA&- NOPPB 4 T* V 5 7 YQ *&BCRO O SOBB&A &L 12*+; S&COA A CO SPB- &L ARBRO DNCP GOBC NNA&- NOPPB 4 T* V 5 7 >Q *&BCRO O SOBB&A &L 12*+, S&COA A CO SPB- &L ARBRO DNCP GOBC NNA&- NOPPB 4 T* V 5 7
$%& (*+ $$%& (*+, $$%& $$%&- $%& $%&./0 12.34567849.(56: ;9=177456 5> $$%& (*+, $%& (*+, $$%&, $$%&-, $%&,.6 $%& 46 @=1.73 A.6B1= $%& ( *+,- $%& ( $%& ( $%& ( $%& ( 0.D2(1P708: 4:14Q 0 ; >R > $,&./011232.04256 $7*58 95/7*: ;.*.* -=: ; > > 8:=6064 42*:1 &:614870/ 140471 8:*:65@071: 514(*:65@071: A, *:40140121 140471 512429:,:=0429: B789290/ 140471 B789290/ C:04D + G+ && (*+,- && ( > > R && ( $%& ( $%& ( $%& (*+ $$%& (*+ $$%& $$%&- $%& $%&./0 12.34567849 /13C116 ;9=177456 5> $%& (*+, $$%& (*+, $$%&, $$%&-, $%&, $%&,.6 A2464B59.38525:4B.2 %.=.(131=7 46 @=1.73 A.6B1= $%& (*+,- && (*+,- && ( && ( $%& ( $%& ( > > 0 L 0 && M *0482N *:40//5@854:2601:1O $%& M 42117: 26D2L24581 53 *0482N *:40//5@854:2601:1.D2(1P708: 4:14Q 0 ; >R >Q L ; >R > 0 0 0 L 0 > > 0 > L 0 0 L > 0 > $% & ( *+$% & ( $% $%, *+$%- *+$% && ( *+,- $%& ( *+,- && ( && ( $%& ( $%& ( $%& ( *+,- ; >R > && ( *+,- G+ ; >R >Q ; >R > && ( ; >R > $%& ( ; >R > && ( ; >R >Q ; >R > G+ + && ( && ( $%& ( $%& (
B $%& ( *+, && ( *+, && ( 12 62 && (- $%& (. $%& ( +=$6>,2:7 $$6>,2:7 $$6> $$6> +=$6> +=$6> CC S-3 C N D DB $$6> $$6> CCB O P 40 5>$%%. +=$6>,2:7 $$6>,2:7 $$6> $$6> $$6> +=$6> +=$6> %34L M CB Q DB D $$6>,2:7 $$6> $$6> $ Q DB DR DB D L M %& ( &*+&,-. / 0*-&.1 &23-* 4*52.1+3 6&31*. +2 17-89:&1+2 ; $ :,1+=&*+&1- >-5*-..+2 2&,;.+. $%& (& (( (& &*( +*,-. /-0*,% 12 %34.%((-5 62 %34.%((-5 78% 6.%85 5& 5*,9%. $%5(&.* 0 (& &*( +:$ ;0 ((; &-5 +.% &,%5& (& &*( +=$6> %34.%((-5 +=$6> %34.%((-5 $$6> %34.%((-5 +=$6>,2:7 %34.%((-5 $$6>,2:7 %34.%((-5 $$6> %34.%((-5 @ A B CD B D DB A DB B C DB C B B A B GGC A DB C A DB DCD B D A DB D DB G B GC 1 DB G B DC DB DB B G DB G B G DB DB CD DB C DB CC DB G DB D DB DB 0 B GD B B D B DB D DB C DB D CB C B DB GD DB DD B C DB B G B 8B DB DD DB DDG DB DB DB DB GD DB DB D DB D DB DB DB DD DB DB GC DB D 134 L @ M DB DG DB CC B D DB B B D B B GD DB C DB C DB G CB DB G B C GB $$6>,2:7 $$6> $$6> X8B P 40 5>$%%. (*.// 0 ;*./%( - 9.% (& ; 5;%. 9 (% -5 &Y% 4-(&/% -. 5%8 &/% $$6>,2:7 7Z $$6>,2:7T @Z $$6> 4.-&%5T SZ $$6> 4.-&%5 7L $$6> M @L $$6> M R $ $$6> $$6> +=$6> +=$6> T +=$6> +=$6> $$6> $$6> U $$6> $$6> V R R GR W +=$6>,2:7 +=$6> $$6>,2:7 $$6> $$6>
: $%& ( $%& (* && ( $%& ( +,-. && ( +,-. $%& ( && ( / 0 1 2 && ( +,-. 3, && ( && ( && ( && ( && ( / * 4 5 6 2 && ( +,-. && ( && ( 789 && ( *6: && ( && ( +,-. && ( && ( && ( && ( $%& (* $%& ( && ( / * 2 / 2 / 2 / 0 2 / 1 2 / 6 2 / 2 $;=>@;;AB(&;CCB;.5 ;;DD8 5 8GC; &5 >C ;: &;CAB9 +>C;8A8C>B;@>( B++8A>;CB=> A8C>B. +;AD>A 8L ;MMA>@@B=>>@@ B NA>;@C ;AB8+; / O2: 7;>A5 *P5 P Q6 R **1 S **6 : / & 2 : : * * S 0*: : /O2 : TT * T1 S *T: >>A UO5 &;CAB@B@; V&5 O>@>,.5 >C ;: 39A>@@B8 8L +8@C +;CAB9 +>C;8AC>B;@> L;+B +>+N>A B NA>;@C ;>A@ A>A>@>C@ ; C+8A(BW>W G8@C A>@8@> / O2:.+ O ;CG85 *65 *0 Q* R S P: V;A>8 75.=;X;C8 Y5 7;A>; 75 >C ;: $B@@> BGBNBC8A 8L +>C;8A8C>B;@> Q $%& R (* ;W A8BL>A;CB=> N>G;=B8A 8L 8; NA>;@C ;>A >@/ O2: ZA>;@C 7;>A,>@ $A>;C *5 10 1 S 00: [8@GBD;\; $5 ];BC8G &5 $@NA;;.5 >C ;: $B@@> BGBNBC8A 8L +;CAB9 +>C;8A8C>B;@>(* B CG> ;@+; 8L ;CB>C@ \BCG M;@CAB ;AB8+; ; 8@@BN> +;AD>A L8A @>A8@; B=;@B8 ;W +>C;@C;@B@ / O 2 : 7;>A5 *5 P6 Q *T R * S *1: / 2